Confronting publication bias: A cohort design for meta‐analysis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (56)
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
1959 • 14,850 citations
The file drawer problem and tolerance for null results.
1979 • 7,706 citations
Statistical Methods in Cancer Research
1980 • 6,825 citations
The Combination of Estimates from Different Experiments
1954 • 4,769 citations
Linear Regression Analysis
2013 • 2,838 citations
Analysis of Binary Data
2008 • 2,760 citations
ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE
1955 • 2,755 citations
The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control Trial
1978 • 1,634 citations
A method for assessing the quality of a randomized control trial
1981 • 1,370 citations
Clinical trials: A practical approach
1984 • 1,236 citations
The American Soldier: Adjustment During Army Life.
1949 • 1,179 citations
Combining results of independent studies.
1978 • 891 citations
Publication Decisions and their Possible Effects on Inferences Drawn from Tests of Significance—or Vice Versa
1959 • 865 citations
Publication bias: the case for an international registry of clinical trials.
1986 • 750 citations
Randomized Clinical Trials
1976 • 539 citations
Publication Decisions and Their Possible Effects on Inferences Drawn from Tests of Significance--Or Vice Versa
1959 • 533 citations
Evidence Favoring the Use of Anticoagulants in the Hospital Phase of Acute Myocardial Infarction
1977 • 439 citations
Combining Independent Tests of Significance*
1954 • 353 citations
A Survey of Clinical Trials of Antibiotic Prophylaxis in Colon Surgery: Evidence against Further Use of No-Treatment Controls
1981 • 345 citations
Biostatistics in Clinical Medicine.
1988 • 329 citations
Advanced Ovarian Adenocarcinoma
1978 • 324 citations
Effect of Intravenous Streptokinase on Acute Myocardial Infarction
1982 • 206 citations
Fate of Cardiology Research Originally Published in Abstract Form
1980 • 166 citations
Designs for Experiments — Parallel Comparisons of Treatment
1983 • 150 citations
Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma.
1982 • 137 citations
2. Linear Regression Analysis
1976 • 134 citations
Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycin
1981 • 113 citations
Chemotherapy of Ovarian Cancer
1984 • 107 citations
Clinical trial methodology
1978 • 106 citations
Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease.
1979 • 105 citations
A measure to aid in the interpretation of published clinical trials
1985 • 102 citations
Biostatistics in Clinical Medicine.
1983 • 102 citations
A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus adriamycin plus cyclophosphamide in ovarian carcinoma
1983 • 93 citations
Long-term survival after chemotherapy for advanced epithelial ovarian carcinoma
1984 • 91 citations
Guidelines for publishing papers on cancer clinical trials: responsibilities of editors and authors.
1983 • 85 citations
Treatment selection for cancer patients: Application of statistical decision theory to the treatment of advanced ovarian cancer
1985 • 82 citations
Common Epithelial Cancer of the Ovary
1985 • 76 citations
Strategy and alternate randomized designs in cancer clinical trials.
1982 • 63 citations
The Clinical Trial
1981 • 59 citations
Advanced ovarian carcinoma: A prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF)
1981 • 53 citations
Chemotherapy in advanced ovarian cancer
1984 • 47 citations
Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of cytoxan, 5-fluorouracil and dactinomycin
1980 • 44 citations
Advanced Ovarian Cancer: A Prospective Randomised Trial of Chlorambucil Versus Combined Cyclophosphamide and Cis-diamminedichloroplatinum
1982 • 36 citations
Single agent vs combination chemotherapy in the treatment of ovarian cancer.
1977 • 36 citations
A randomized trial of Melphalan alone versus combination chemotherapy in advanced ovarian cancer
1980 • 30 citations
Comparison of melphalan with cyclophosphamide, methotrexate, and 5-fluorouracil in patients with ovarian cancer
1984 • 26 citations
Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancer
1980 • 26 citations
cis-platinum, adriamycin, and hexamethylmelamine versus cyclophosphamide in advanced ovarian carcinoma
1983 • 21 citations
Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.
1979 • 18 citations
MEDICAL RESEARCH COUNCIL STUDY ON CHEMOTHERAPY IN ADVANCED OVARIAN CANCER
1981 • 18 citations
Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.
1980 • 15 citations
Ovarian cancer.Use of multiple modality programs involving surgery, radiation therapy and chemotherapy
1977 • 12 citations
A controlled clinical trial in advanced ovarian cancer
1982 • 8 citations
Data recycling and misreading: two potential errors in pooled data from small studies.
1984 • 7 citations
[A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
1982 • 2 citations
Deleted Work
1955 • 0 citations
Cited By (0)
No citing papers found in database